Astra Zeneca i exklusivt licensavtal med Alteogen

Astra Zenecas dotterbolag ingår ett ett exklusivt licensavtal med det sydkoreanska bolaget Alteogen. Målet är att utveckla subkutana behandlingsalternativ för cancerpatienter.

Clean solutions - Handling viscose substances with precision

Paar, is one such solution – and uses electric axes and control systems from Festo.

Level up your medical expertise

Learn from innovative industry speakers from leading MedTech companies at ZEISS Quality Innovation Days.

Optimize Your Visibility

ZEISS presents our newest VersaXRM® 730 3D X-ray microscope.

Ossiform: Quality control of 3D printed bone implants

Ossiform chose the GOM Scan 1.

To build trust, one must be able to say “I don’t know” – whether human or AI

Will AI strengthen or break down trust? It depends on whether we can understand and accept its limitations, and our own, writes Sarah Lidé in a column.

Samuel Lagercrantz: The government’s performance in healthcare and life sciences so far

Since the change of government in Sweden, developments in the healthcare sector have shown promising signs, but the outlook in life sciences is less promising, ...

Looking for greater Nordic cooperation – “We have Norway and Finland in our sights”

How can Medicon Valley Alliance bring the big pharmaceutical companies back to the organisation? Life Science Sweden discussed this topic and others with the cl...

Individual DNA passport could result in fewer drug side effects

You may be required to show a DNA passport when you pick up medicines at the pharmacy in the future. According to a new study, patients might suffer 30% fewer s...

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

She creates pharmaceuticals on a 3D printer

The correct dosage for each individual, regardless of whether the pharmaceutical is for a seriously ill child or a frail elderly person, is the mission of a wel...

Ancient DNA provides new insights – “The immune system lost its job”

Ancient bone remains from our ancestors have provided new insights into the prevalence of multiple sclerosis. By looking back in time, researchers can provide a...

JMP Statistical Discovery

KI’s new President: “We need to work closer together”

A closer link between research and education and a stronger “we-feeling” are aims that Annika Östman Wernerson sets out to achieve as the new President of Karol...

Neanderthal gene variants may cause Viking disease

A new study suggests that the so-called Viking disease, which affects the hand function in many older people, may be linked to gene variants inherited from Neanderthals.

Wusson Accelerator AB

Nobelpris för kvantforskning i kirurgins tjänst

Tv-skärmar, LED-lampor – och medicinsk kirurgi – är områden som dragit nytta av forskningen som belönas med årets Nobelpris i kemi. Priset går till tre forskare...

62-åring fick njure från gris i unik transplantation – "Återhämtar sig bra"

Amerikanska kirurger har genomfört den första transplantationen av en njure från en genmodifierad gris till en människa med njursjukdom.

ZEISS Quality Innovation Days: April 15 – 19, 2024

Be there when industry experts give exciting insights into different applications and trends in 90 minutes on various theme days.

Nytt europeiskt patent skyddar formulering från Index Pharmaceuticals

Index Pharmaceuticals har beviljats ett nytt europeiskt formuleringspatent för sin läkemedelskandidat cobitolimod som utvärderas som behandling av ulcerös kolit...

Vinnova is going to establish a new innovation cluster

Vinnova, the Swedish Agency for Innovation Systems, has been commissioned by the government to establish a national innovation cluster for advanced medicines.

Marie Gårdmark: ”Interchangeable biological medicines – soon in a pharmacy near you?”

”Generic competition is an effective way to push down drug prices, but it has not worked equally well for biosimilars. Biosimilars require more time to gain mar...

Bioarctics forskningschef Johanna Fälting tar plats i VR:s ämnesråd

Bioarctics forskningschef Johanna Fälting och läkaren Markus Lingman har utsetts till nya ledamöter i Vetenskapsrådets ämnesråd för medicin och hälsa.

Omvänt förvärv ska ta Flerie till börsen – ”Viktigt steg i bolagets plan”

Läkemedelsinvesteraren Flerie Invest tar en genväg till börsen genom ett omvänt förvärv av forskningsbolaget Index Pharmaceuticals.